Octahydro-Cyclopenta[B]Pyrrole-2-Carboxylic Acid Phenylmethyl Ester

Hydrogenolytic debenzylation of octahydro-cyclopenta[B]pyrrole-2-carboxylic acid phenylmethyl ester tosylate salt at multi-kilogram scale proceeds over 5% Pd/C (sulfided, 50% water wet) in a 2:1 (v/v) ethanol/THF solvent matrix under 0.15–0.30 MPa H₂ gauge. The semi-continuous trickle-bed procedure adopted on a Hastelloy C-22 fixed-bed contactor addresses the catalyst attrition and downstream palladium contamination risks inherent in slurry reactors. Hydrogen uptake rate, monitored by mass flow controller integrated with supervisory control, dictates the end-point: gas consumption drops to <0.05 NL/min at constant pressure after 2.2–2.8 h. Catalyst lifetime reaches 12–15 cycles before regeneration with aqueous sodium bicarbonate wash, as palladium crystallite sintering beyond 4.5 nm median diameter (XRD line broadening) reduces turnover frequency below 0.25 mol_H2·g_Pd⁻¹·h⁻¹. The product, (2S,3aS,6aS)-octahydrocyclopenta[b]pyrrole-2-carboxylic acid, is isolated as a crystalline solid after pH adjustment to isoelectric point 5.8–6.2 with ammonium hydroxide, filtration on a 0.2 μm in-line cartridge, and spray drying at inlet temperature 140 °C. This intermediate subsequently undergoes mixed-carbodiimide-mediated amide coupling with N-[(S)-1-ethoxycarbonyl-3-phenylpropyl]-L-alanine (ramipril side-chain acid) in dichloromethane at −5 to +2 °C, using 1.05 eq of the tosylate salt form of the benzyl ester relative to the side-chain acid, to deliver ramipril benzyl ester. The addition of stoichiometric N-methylmorpholine (1.0 eq) liberates the free amine in situ, while 1.10 eq EDC·HCl and 1.10 eq HOBt·H₂O drive activation. Reverse-addition of the side-chain mixed anhydride over 45–60 min mitigates the formation of the Δ^3,4-enamide dehydration side-product. Final ramipril API, after subsequent hydrogenolytic deprotection, is crystallized from aqueous acetic acid/acetone to yield polymorphic Form I, with particle size d₉₀ controlled to <90 µm by wet milling. Conformance with US Pharmacopeia monograph USP 43-NF 38 Ramipril and European Pharmacopoeia monograph Ph. Eur. 10.0, 1367 is demonstrated through specific rotation [α]_D²⁰ −52.0° to −57.0° (c=1, 0.1 M HCl), assay 99.0–101.0% by HPLC, and impurity profiles controlled per ICH Q3A(R2). Process design follows ICH Q11 principles with critical process parameters identified via multivariate batch evolution modeling.

The first-principles kinetic model for the carbodiimide-mediated amide segment condensation incorporates an isocyanate intermediate that partitions between productive amide formation and intramolecular N-acylurea rearrangement. The rate of formation of the undesired N-acylurea adduct exhibits an Eyring activation enthalpy of 58.3 kJ·mol⁻¹ derived from variable-temperature ATR-FTIR monitoring of the carbonyl stretching region (1755 cm⁻¹). Maintaining the jacket outlet temperature on the 2000 L glass-lined reactor at −8 °C through a secondary brine loop reduces the N-acylurea concentration in the washed organic phase to <0.15 area%. A subsequent scavenging step with 2-dimethylaminoethylamine (0.08 eq) chemoselectively derivatizes residual N-acylurea into a water-extractable quaternary salt, further lowering the carry-over to <0.05 area% prior to hydrogenolysis. This tandem control strategy obviates column chromatography at scales exceeding 50 kg of input benzyl ester.

Incorporation of the octahydro-cyclopenta[b]pyrrole-2-carbonyl fragment (octahydroCPP) as a constrained proline surrogate into peptide backbones modulates the backbone ψ and φ torsion angles toward those of a type VI β-turn, conferring metabolic resistance toward prolyl oligopeptidase (POP, EC 3.4.21.26). The Fmoc-protected derivative, synthesized from the benzyl ester by one-pot hydrogenolytic debenzylation followed by fluorenylmethyloxycarbonyl chloride acylation in dioxane/aqueous Na₂CO₃ at 0–5 °C, is employed in microwave-assisted solid-phase peptide synthesis (SPPS) on a CEM Liberty Blue automated instrument. Coupling of Fmoc-octahydroCPP-OH (3.0 eq relative to resin substitution) is mediated by 2.85 eq HCTU in the presence of 6.0 eq N,N-diisopropylethylamine in DMF, with double coupling at 75 °C for 5 min each to overcome the slow acylation kinetics arising from the bicyclic secondary amine. Resin loadings of 0.25 mmol·g⁻¹ on Rink amide ChemMatrix support give isolated crude purities of 82–89% for octahydroCPP-containing nonapeptides. Cleavage with reagent K (TFA/thioanisole/water/phenol/EDT 82.5:5:5:5:2.5 v/v) for 3 h at room temperature yields the fully deprotected peptide, isolated by cold ether precipitation and preparative RP-HPLC (C₁₈, 250 × 21.2 mm, 5 µm, gradient 10→45% MeCN in 0.1% TFA over 30 min). The final product application spans protease-resistant lead peptides for serine protease inhibitors, CGRP receptor antagonists, and DPP-IV enzyme probes. Analytical characterization adheres to USP <621> for chromatographic purity and ICH Q6B for peptide specification, with compendial identity confirmed by high-resolution mass spectrometry (error <3 ppm) and amino acid analysis (>90% theoretical residue molar ratios).

When Enantiomeric Ratio Drives Catalyst Choice in Asymmetric Reductive Amination

The free carboxylic acid derivative, (2S,3aS,6aS)-octahydrocyclopenta[b]pyrrole-2-carboxylic acid—obtained quantitatively from the benzyl ester by alkaline hydrolysis with 1.2 eq LiOH in THF/water at 20–25 °C over 4 h—serves as a chiral ligand for titanium(IV)-catalyzed enantioselective reductive amination of prochiral aryl ketimines. In a method adapted from the general procedure of Nolin et al., the octahydroCPP acid (5 mol%) is combined with 1.0 eq Ti(OiPr)₄ and stirred in anhydrous tetrahydrofuran for 1 h to generate the active titanacycle complex. A subsequent addition of 1.0 eq of 3,4-dimethoxyphenylacetone N-benzylimine (0.5 M in THF) and pressurization with hydrogen to 5.0 MPa at 40 °C furnishes the corresponding primary amine after acidic work-up and distillation, with an enantiomeric excess of 94–98% ee (S configuration) as determined by chiral HPLC on a Chiralpak IA-3 stationary phase (250 × 4.6 mm, 3 µm, hexane/EtOH/DEA 90:10:0.1, 1.0 mL/min, UV 254 nm). The substrate scope has been validated for ketimines bearing electron-neutral and electron-rich aryl substituents; electron-deficient variants (σ_m > +0.35) exhibit diminished conversion (<45%) under the standard conditions owing to catalyst deactivation by nitrile coordination. The operational boundary thus restricts the ketimine substrate to those with a Hammett σ_meta constant below +0.30. Scale-up to 500 mL autoclave provides throughputs of 15 g·L⁻¹·h⁻¹ of isolated chiral amine after vacuum fractional distillation at 105–110 °C / 0.5 mmHg. The generated chiral primary amines are building blocks for the synthesis of divalent protease inhibitor pharmacophores and monoamine reuptake inhibitor candidates. Laboratory safety compliance follows ISO 45001:2018 occupational health and safety management, with chemical risk assessment guided by REACH regulation (EC 1907/2006), though full GMP is not implemented at this synthetic methodology stage.

Available in catalog entries ranging from 10 g research aliquots to 100 kg commercial batches under flexible quality agreements, (2S,3aS,6aS)-octahydrocyclopenta[b]pyrrole-2-carboxylic acid phenylmethyl ester is supplied as either the free amine or the crystalline p-toluenesulfonate salt. The salt form demonstrates superior shelf stability under ICH Q1A accelerated storage conditions (40 °C/75% RH, 6 months) with less than 0.2% de-esterification detected by HPLC, owing to the non-nucleophilic character of the tosylate counterion. Typical composition for the tosylate is assay ≥98.5% (by anhydrous, non-salt corrected titration), water content ≤0.5% (Karl Fischer), and single largest unspecified impurity ≤0.10 area% by HPLC at 210 nm. Derived modifications conducted under contract include reductive methylation at the pyrrolidine nitrogen (HCHO, NaBH₃CN, MeOH, pH 5, 20 °C), Curtius rearrangement of the acyl azide to the primary amine with trapping as the Boc-carbamate, and conversion to the Weinreb amide for subsequent ketone synthesis. Each custom synthesis batch is accompanied by a certificate of analysis that tabulates the results against the internal specification (chromatographic purity by USP <621> method, residual solvents by USP <467>, and identity by ¹H, ¹³C NMR and HRMS). For GMP deliveries, the quality system follows the ICH Q7 Guide for Active Pharmaceutical Ingredients with a dedicated quality risk management plan per ICH Q9, supported by full audit trail capabilities on the distributed control system.

What Limits Reaction Yield in Bulk Amide Coupling of the Benzyl Ester?

The yield ceiling observed in the formation of the ramipril benzyl ester penultimate intermediate is traced to a competitive, pH-dependent epimerization channel at the α-carbon of the side-chain L-alanine derivative. Mechanistically, the mixed anhydride species generated from N-[(S)-1-ethoxycarbonyl-3-phenylpropyl]-L-alanine and isobutyl chloroformate at −15±3 °C undergoes racemization via oxazol-5(4H)-one formation when the local apparent pH exceeds 8.5 in the aqueous-organic interfacial film. In a 1000 L glass-lined baffled reactor with a retreat-curve impeller operating at 85 rpm tip speed (1.5 m·s⁻¹), the heterogeneous activation with 1.08 eq isobutyl chloroformate in the presence of 1.12 eq N-methylmorpholine generates a dynamic emulsion layer where the amine release lags behind anhydride formation. This lag creates a temporary alkaline microenvironment, resulting in 0.8–1.5 area% of the undesired (R,S)-diastereomer if the coupling partner is added too early. The operating protocol therefore stipulates an ageing period of exactly 12 min after anhydride formation, end-pointed by in-line ReactIR monitoring of the mixed anhydride carbonyl band at 1812 cm⁻¹, before the rapid transfer of the pre-cooled benzyl ester tosylate solution. Mass transfer limitations intrinsic to scale amplify local concentration gradients; computational fluid dynamics simulations of the Rushton turbine discharge zone predict turbulent kinetic energy dissipation rates of ε ≈ 0.6 m²·s⁻³, which contrast with the ε < 0.15 m²·s⁻³ observed in laboratory vortex mixers, partially explaining the yield differential of 6–10% between bench and plant scales. Corrective measures include the use of a semi-continuous addition mode injecting the benzyl ester solution at a rate that matches the consumption rate derived from reaction calorimetry (ΔH = −78.5 kJ·mol⁻¹), achieving a final isolated ramipril benzyl ester yield of 91–93% after crystallization from ethyl acetate/heptane. Process qualification under ICH Q11 considers the anhydride ageing time, addition rate, and jacket temperature as critical process parameters, with their proven acceptable ranges validated by a Design of Experiments comprising 27 runs at 10 kg scale.

For establishment of the impurity profile mandated by the ramipril monograph Ph. Eur. 10.0 and the FDA new drug application requirements, the enantiomerically pure benzyl ester is utilized as a precursor to synthesize and characterize the specified process-related impurities. Exposure of the benzyl ester to 0.1 M HCl in THF at 50 °C for 6 h yields the des-ethyl derivative; treatment with triethylamine (1.2 eq) in refluxing dichloromethane promotes intramolecular diketopiperazine formation between the benzyl ester and the side-chain acid moiety. These isolated impurities, purified by preparative HPLC (C₁₈, 100 Å, 10 µm, 250 × 50 mm, isocratic MeCN/0.1% TFA) and lyophilized, serve as certified reference materials traceable to a secondary standard calibrated against the EP chemical reference substance. The calibration protocol uses mass balance, quantitative NMR (qNMR) with 1,4-bis(trimethylsilyl)benzene-d₄ as internal standard, and Karl Fischer coulometry to assign absolute purity values. Each lot carries an uncertainty budget expanded with coverage factor k=2, and the certificate references ISO/IEC 17025:2017 and ISO 17034:2016 for reference material producers.